Juul’s E-Cigarettes Back on Market as FDA Rescinds 2022 Ban for Further Review

Juul’s E-Cigarettes Back on Market as FDA Rescinds 2022 Ban for Further Review

The US Food and Drug Administration (FDA) announced on Thursday that it would reverse its 2022 order, which had temporarily halted the sale of Juul’s products, including its e-cigarettes.

This latest decision comes in the wake of Juul’s recent application for FDA authorization of new menthol-flavored pods designed for use with its e-cigarette devices.

The agency’s earlier ban, citing insufficient safety evidence and concerns over potentially hazardous liquid, has now been suspended pending further review.

Background of the Ban

In 2022, the FDA issued a ban on Juul’s four varieties of tobacco and menthol-flavored pods, as well as its e-cigarette device.

The agency concluded that Juul had not provided adequate evidence to prove the safety of its products, highlighting potential risks associated with the liquids used in the e-cigarettes.

This ban was, however, stayed a month later following an appeal by Juul, allowing the company to continue its operations temporarily.

Current Status of Juul’s Application

The FDA’s recent action does not imply an outright authorization or denial of Juul’s marketing application. Instead, it means that the company’s applications are now under review once again.

The FDA emphasized that this rescission is simply a return to the pending status and does not indicate a final decision on the safety or marketability of Juul’s products.

Legal Challenges and FDA’s Regulatory Role

The marketing denial orders issued by the FDA have been contested by e-cigarette manufacturers across multiple states.

These court decisions have influenced the FDA’s approach to product reviews. The agency began regulating e-cigarette devices and vapes in August 2016, and to date, it has authorized 23 e-cigarette products for sale in the United States.

Despite the ongoing review of Juul’s application, the FDA reiterated that all e-cigarette products require its authorization to be legally marketed.

No Prohibition on Ownership

It is important to note that while the FDA had banned the sale of Juul products, there has been no rule against owning or using a Juul device.

The ban included specific Juul products: JUULpods Virginia Tobacco (five percent and three percent) and Menthol (five percent and three percent).

The Vaping Industry Under Scrutiny

The vaping industry, including Juul, has faced intense scrutiny from the FDA due to allegations of contributing to increased e-cigarette use among young people. Critics argue that e-cigarettes act as a gateway for smoking initiation among youths.

However, manufacturers maintain that their products are safer alternatives to traditional cigarettes, as they lack toxic smoke and can aid in smoking cessation.

Legal Settlements and Marketing Restrictions

In a significant development last year, Juul Labs Inc. agreed to pay $462 million to settle lawsuits with six states and the District of Columbia.

This settlement, the largest to date for Juul, addressed the company’s role in the youth vaping surge. The agreement included several restrictions on Juul’s marketing and distribution practices.

For instance, Juul is barred from any marketing that targets individuals under 35 years of age and must limit purchase quantities in retail and online stores.

Juul’s Market Influence and Future Prospects

Juul’s rise to prominence in the vaping market was driven by the popularity of flavors such as mango, mint, and crème brûlée.

However, this popularity also led to widespread use among teenagers, many of whom became addicted to Juul’s high-nicotine pods.

The company’s future now hinges on the FDA’s ongoing review and its ability to comply with stringent marketing and distribution regulations.


The FDA’s decision to reverse its 2022 ban on Juul products and return the company’s applications to pending status marks a crucial moment in the regulatory landscape of e-cigarettes.

As Juul awaits the FDA’s final decision, the company remains under scrutiny for its past marketing practices and their impact on youth vaping.

This development underscores the ongoing tension between public health concerns and the vaping industry’s claims of offering safer alternatives to smoking.

TDPel Media

This article was published on TDPel Media. Thanks for reading!

Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn

Advertisement: Download Vital Signs App (VS App)